Black Cohosh Root Extract
Cimicifuga racemosa rhizome extract standardized to triterpene glycosides for women's health. Under 1302.19.4140 as therapeutic vegetable sap/extract.
Import Duty Rates by Country of Origin
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• 2.5% actein standardization; monitor for hepato-toxicity markers
• US-grown predominant; provide wild-crafted sustainability docs
• EU Ph
• Eur. monograph compliance aids customs acceptance
Related Products under HTS 1302.19.41.40
Red Ginseng Concentrate Liquid
Steamed and dried Korean red ginseng processed into liquid concentrate for beverage and supplement base. HTS 1302.19.4140 applies to this ginseng sap/extract with therapeutic claims, excluding confectionery or alcoholic forms.
Pau d'Arco Inner Bark Extract
Tabebuia impetiginosa bark extract containing lapachol, used for antifungal therapeutic properties. Classified in 1302.19.4140 as 'other' vegetable extract with prophylactic/therapeutic effects, not a finished medicament.
Cat's Claw Bark Extract
Uncaria tomentosa (uña de gato) bark extract standardized to oxindole alkaloids for immune support. HTS 1302.19.4140 covers this as vegetable extract with therapeutic properties, excluding standardized medicaments.
Pygeum Africanum Bark Extract
Prunus africana bark extract standardized to phytosterols for prostate health support. Classified 1302.19.4140 as African cherry tree vegetable extract with therapeutic properties.
Saw Palmetto Berry Extract
Serenoa repens berry extract rich in fatty acids for urinary tract health. HTS 1302.19.4140 for this vegetable extract with prophylactic properties, prior to encapsulation.
Panax Ginseng Root Extract
A concentrated aqueous extract derived from the roots of Panax ginseng, used in dietary supplements for its adaptogenic properties. Classified under HTS 1302.19.4140 as a vegetable extract of ginseng with therapeutic properties, not qualifying as a medicament under heading 3003 or 3004.